Unlock instant, AI-driven research and patent intelligence for your innovation.

Sesquiterpene in wild mugwort and its pharmaceutical composition and its preparation method and application

A sesquiterpene and composition technology, applied in the direction of drug combination, pharmaceutical formula, medical preparations containing active ingredients, etc., can solve the problem that there is no anti-hepatic fibrosis drug of compound 1-13 and its pharmaceutical composition

Active Publication Date: 2022-05-13
KUNMING INST OF BOTANY - CHINESE ACAD OF SCI
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, there is no report of compound 1-13 in the prior art, and there is no report of compound 1-13 and its pharmaceutical composition as an anti-hepatic fibrosis drug

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Sesquiterpene in wild mugwort and its pharmaceutical composition and its preparation method and application
  • Sesquiterpene in wild mugwort and its pharmaceutical composition and its preparation method and application
  • Sesquiterpene in wild mugwort and its pharmaceutical composition and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Preparation of Compound 1-13:

[0024]The dry aerial part of Artemisia chinensis is crushed, extracted by cold soaking with 95% ethanol twice, each time for 4 days, the ethanol extracts are combined, and the ethanol extract is recovered under reduced pressure. The extract was dispersed in water and extracted with ethyl acetate, then concentrated to the ethyl acetate extract. Then the ethyl acetate extract was subjected to silica gel column chromatography with ethyl acetate-petroleum ether (0:100, 5:95, 10:90, 20:80, 40:60 and 100:0) as the eluent gradient Elution gave six fractions of Fr.A-Fr.F. Fraction Fr.C was subjected to silica gel column chromatography (acetone-petroleum ether, 5:95, 10:90 and 20:80) to obtain three fractions Fr.C1-Fr.C3. Fraction Fr.C1 was subjected to MCI gelCHP 20P column chromatography (water-methanol, 10:90 and 0:100) and semi-preparative HPLC (water-acetonitrile, 30:70) to obtain compound 13 (12 mg). Fraction Fr.C2 was subjected to MCI ge...

Embodiment 2

[0162] Cytotoxic activity of compounds 1-13 against HSC-LX2.

[0163] 1. Materials and Methods

[0164] 1.1 Materials

[0165] Human hepatic stellate cells line LX2 (HSC-LX2) was purchased from Shanghai Ji Ning Biotechnology Co., Ltd.; RPMI-1640 medium and fetal bovine serum were purchased from Gibco BRL (NY, USA); MTT was purchased from Guangzhou Saiguo Biotechnology Co., Ltd.

[0166] 1.2 Instruments

[0167] Flex Station 3 desktop multifunctional microplate reader (Bio-RAD 680, the United States); analytical balance (AG135, Metler Toledo, China); incubator (DHP-9082, Shanghai).

[0168] 1.3 Experimental process

[0169] MTT method was used to measure the toxic activity of samples on HSC-LX2 cells. HSC-LX2 cells were cultured in RPMI-1640 medium containing 10% fetal bovine serum. Cells grown in logarithmic phase were taken at 1×10 4 Inoculate in a 96-well plate at the density of each well, and replace the maintenance solution with the culture medium containing differe...

preparation Embodiment 1-7

[0179] In the following preparation examples, conventional reagents are selected, and preparations are prepared according to existing conventional methods. This application example only reflects that at least one of the compounds 1-13 of the present invention can be prepared into different preparations. For specific reagents and The operation is not specifically limited:

[0180] 1. With at least one of the compounds 1-13 prepared in Example 1, after dissolving with DMSO, add water for injection according to a conventional method, fine filter, potting and sterilizing to make an injection, the concentration of the injection is 0.5 -5 mg / mL.

[0181] 2. After dissolving at least one of the compounds 1-13 prepared in Example 1 with DMSO, dissolve it in sterile water for injection, stir to dissolve it, filter it with a sterile suction filter funnel, and then sterilize it. filtered, divided into ampoules, freeze-dried at low temperature and sealed aseptically to obtain a powder in...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
Login to View More

Abstract

The present invention provides 13 new sesquiterpenes shown in structural formula (I), artemilavanolides C-F (1-4), artemlavandulolides A-G (5-11), artemlavanin B (12) and artemlavanin A (13), and Its preparation method and application, pharmaceutical composition and application thereof relate to the technical field of medicine. The compound 1-13 has obvious cytotoxic activity on human hepatic stellate cells (HSC-LX2), can form a pharmaceutical composition with a pharmaceutically acceptable carrier or excipient, and can be used to prepare anti-hepatic fibrosis drugs.

Description

Technical field: [0001] The invention belongs to the technical field of medicines. Specifically, it relates to sesquiterpene artemilavanolides C-F (1-4), artemlavandulolides A-G (5-11), artemlavanin B (12) and artemlavanin A (13), their preparation methods and applications, pharmaceutical compositions and applications thereof. Background technique: [0002] Liver fibrosis is an inevitable stage in the development of various chronic liver diseases to cirrhosis, and its causes include viral hepatitis, excessive alcohol intake, chemical poisons or drugs, parasitic infections, genetic and metabolic diseases, etc. When the liver cells of the human body are damaged, a series of repair reactions of the body will be triggered, specifically manifested as the activation and regeneration of myofibroblasts, and the massive production and deposition of extracellular matrix. The development process of sclerosis seriously affects the quality of life of the human body. At present, the occ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D307/00C07D307/92C07C69/757C07C67/48A61K31/365A61K31/215A61P1/16
CPCC07D307/00C07D307/92C07C69/757A61P1/16C07C2602/28
Inventor 陈纪军申程耿长安黄晓燕马云保李天泽张雪梅
Owner KUNMING INST OF BOTANY - CHINESE ACAD OF SCI